G1_VACCW
ID G1_VACCW Reviewed; 591 AA.
AC P16713; Q76ZU4;
DT 01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT 01-FEB-1996, sequence version 2.
DT 03-AUG-2022, entry version 92.
DE RecName: Full=Metalloendopeptidase G1;
DE EC=3.4.24.-;
GN OrderedLocusNames=VACWR078; ORFNames=G1L;
OS Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strain
OS WR)).
OC Viruses; Varidnaviria; Bamfordvirae; Nucleocytoviricota; Pokkesviricetes;
OC Chitovirales; Poxviridae; Chordopoxvirinae; Orthopoxvirus; Vaccinia virus.
OX NCBI_TaxID=10254;
OH NCBI_TaxID=9913; Bos taurus (Bovine).
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX PubMed=1994576; DOI=10.1016/0042-6822(91)90491-s;
RA Fathi Z., Condit R.C.;
RT "Genetic and molecular biological characterization of a vaccinia virus
RT temperature-sensitive complementation group affecting a virion component.";
RL Virology 181:258-272(1991).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA Rozanov D.V., Strongin A.Y.;
RT "Vaccinia virus strain WR metalloproteinase GIL.";
RL Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Esposito J.J., Frace A.M., Sammons S.A., Olsen-Rasmussen M., Osborne J.,
RA Wohlhueter R.;
RT "Sequencing of the coding region of Vaccinia-WR to an average 9-fold
RT redundancy and an error rate of 0.16/10kb.";
RL Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN [4]
RP CHARACTERIZATION, AND MUTAGENESIS OF 41-HIS--HIS-45; GLU-112 AND GLU-114.
RX PubMed=7933150; DOI=10.1128/jvi.68.11.7603-7608.1994;
RA Whitehead S.S., Hruby D.E.;
RT "A transcriptionally controlled trans-processing assay: putative
RT identification of a vaccinia virus-encoded proteinase which cleaves
RT precursor protein P25K.";
RL J. Virol. 68:7603-7608(1994).
RN [5]
RP FUNCTION, MUTAGENESIS OF HIS-41; GLU-44 AND HIS-45, AND SUBCELLULAR
RP LOCATION.
RX PubMed=15194761; DOI=10.1128/jvi.78.13.6855-6863.2004;
RA Ansarah-Sobrinho C., Moss B.;
RT "Vaccinia virus G1 protein, a predicted metalloprotease, is essential for
RT morphogenesis of infectious virions but not for cleavage of major core
RT proteins.";
RL J. Virol. 78:6855-6863(2004).
RN [6]
RP FUNCTION.
RX PubMed=15331728; DOI=10.1128/jvi.78.18.9947-9953.2004;
RA Hedengren-Olcott M., Byrd C.M., Watson J., Hruby D.E.;
RT "The vaccinia virus G1L putative metalloproteinase is essential for viral
RT replication in vivo.";
RL J. Virol. 78:9947-9953(2004).
RN [7]
RP ACTIVE SITES, AND MUTAGENESIS OF GLU-35; HIS-41; GLU-44; HIS-45; GLU-110;
RP GLU-112; GLU-114 AND GLU-120.
RX PubMed=16504157; DOI=10.1186/1743-422x-3-7;
RA Honeychurch K.M., Byrd C.M., Hruby D.E.;
RT "Mutational analysis of the potential catalytic residues of the VV G1L
RT metalloproteinase.";
RL Virol. J. 3:7-7(2006).
CC -!- FUNCTION: Probably involved in maturation of some viral proteins by
CC processing them preferentially at Ala-Gly-|-Ser/Thr/Lys motifs. Does
CC not seem to be responsible for the cleavage of major core proteins.
CC {ECO:0000269|PubMed:15194761, ECO:0000269|PubMed:15331728}.
CC -!- COFACTOR:
CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305};
CC Note=Binds 1 zinc ion. {ECO:0000305};
CC -!- SUBCELLULAR LOCATION: Virion {ECO:0000269|PubMed:15194761}.
CC Note=Localizes to the virion core.
CC -!- PTM: Undergoes proteolytic processing during the course of infection.
CC May be cleaved into 46 kDa and 22 kDa products (Potential).
CC {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the peptidase M44 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; J03399; AAB59811.1; -; Genomic_DNA.
DR EMBL; AY497360; AAR88656.1; -; Genomic_DNA.
DR EMBL; AY243312; AAO89357.1; -; Genomic_DNA.
DR RefSeq; YP_232960.1; NC_006998.1.
DR SMR; P16713; -.
DR MEROPS; M44.001; -.
DR DNASU; 3707534; -.
DR GeneID; 3707534; -.
DR KEGG; vg:3707534; -.
DR Proteomes; UP000000344; Genome.
DR GO; GO:0004222; F:metalloendopeptidase activity; IEA:InterPro.
DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR GO; GO:0019058; P:viral life cycle; IEA:InterPro.
DR InterPro; IPR011249; Metalloenz_LuxS/M16.
DR InterPro; IPR005072; Peptidase_M44.
DR Pfam; PF03410; Peptidase_M44; 1.
DR PIRSF; PIRSF015679; Peptidase_M44; 1.
DR SUPFAM; SSF63411; SSF63411; 1.
PE 1: Evidence at protein level;
KW Hydrolase; Metal-binding; Metalloprotease; Protease; Reference proteome;
KW Virion; Zinc.
FT CHAIN 1..591
FT /note="Metalloendopeptidase G1"
FT /id="PRO_0000218446"
FT ACT_SITE 44
FT /evidence="ECO:0000255"
FT BINDING 41
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_note="catalytic"
FT /evidence="ECO:0000255"
FT BINDING 45
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_note="catalytic"
FT /evidence="ECO:0000255"
FT BINDING 112
FT /ligand="Zn(2+)"
FT /ligand_id="ChEBI:CHEBI:29105"
FT /ligand_note="catalytic"
FT /evidence="ECO:0000255"
FT MUTAGEN 35
FT /note="E->A: About 60% loss of processing activity."
FT /evidence="ECO:0000269|PubMed:16504157"
FT MUTAGEN 41..45
FT /note="HLLEH->SLLED: Complete loss of processing activity."
FT /evidence="ECO:0000269|PubMed:7933150"
FT MUTAGEN 41
FT /note="H->A: Complete loss of processing activity."
FT /evidence="ECO:0000269|PubMed:15194761,
FT ECO:0000269|PubMed:16504157"
FT MUTAGEN 44
FT /note="E->A: Complete loss of processing activity."
FT /evidence="ECO:0000269|PubMed:15194761,
FT ECO:0000269|PubMed:16504157"
FT MUTAGEN 45
FT /note="H->A: Complete loss of processing activity."
FT /evidence="ECO:0000269|PubMed:15194761,
FT ECO:0000269|PubMed:16504157"
FT MUTAGEN 110
FT /note="E->A: Complete loss of processing activity."
FT /evidence="ECO:0000269|PubMed:16504157"
FT MUTAGEN 112
FT /note="E->A: Complete loss of processing activity."
FT /evidence="ECO:0000269|PubMed:16504157,
FT ECO:0000269|PubMed:7933150"
FT MUTAGEN 114
FT /note="E->A,D: Complete loss of processing activity."
FT /evidence="ECO:0000269|PubMed:16504157,
FT ECO:0000269|PubMed:7933150"
FT MUTAGEN 120
FT /note="E->A: No effect on processing activity."
FT /evidence="ECO:0000269|PubMed:16504157"
SQ SEQUENCE 591 AA; 68040 MW; 085EFA55BB3DFCBC CRC64;
MIVLPNKVRI FINDRMKKDI YLGISNFGFE NDIDEILGIA HLLEHLLISF DSTNFLANAS
TSRSYMSFWC KSINSATESD AIRTLVSWFF SNGKLKDNFS LSSIRFHIKE LENEYYFRNE
VFHCMDILTF LSGGDLYNGG RIDMIDNLNI VRDMLVNRMQ RISGSNIVIF VKRLGPGTLD
FFKQTFGSLP ACPEIIPSSI PVSTNGKIVM TPSPFYTVMV KINPTLDNIL GILYLYETYH
LIDYETIGNQ LYLTVSFIDE TEYESFLRGE AILQISQCQR INMNYSDDYM MNIYLNFPWL
SHDLYDYITR INDDSKSILI SLTNEIYASI INRDIIVIYP NFSKAMCNTR DTQQHPIVVL
DATNDGLIKK PYRSIPLMKR LTSNEIFIRY GDASLMDMIT LSLSKQDISL KRNAEGIRVK
HSFSADDIQA IMESDSFLKY SRSKPAAMYQ YIFLSFFASG NSIDDILANR DSTLEFSKRT
KSKILFGRNT RYDVTAKSSF VCGIVRGKSL DKTSLVEMMW DLKKKGLIYS MEFTNLLSKN
TFYLFTFTIY TDEVYDYLNT NKLFFAKCLV VSTKGDVENF SSLKKDVVIR V